Abstract
Background:
The Mediterranean diet has been shown to have a beneficial role on various neoplasms, but data are scanty on pancreatic cancer.
Methods:
We analysed data from two case–control studies conducted in Italy between 1983 and 2008, including 362 and 326 pancreatic cancer cases and 1552 and 652 hospital-controls, respectively. A Mediterranean Diet Score (MDS) summarising major characteristics of the Mediterranean diet was used in the two studies separately and overall. Two further scores of adherence to the Mediterranean diet were applied in the second study only, the Mediterranean Dietary Pattern Adherence Index (MDP) and the Mediterranean Adequacy Index (MAI).
Results:
Odds ratios (ORs) for increasing levels of the scores (i.e., increasing adherence) were estimated using multiple logistic regression models. Odds ratio for a MDS score ⩾6 compared with <3 was 0.57 (95% confidence interval (CI) 0.34–0.95) in the first study, 0.51 (95% CI 0.29–0.92) in the second study, and 0.48 (95% CI 0.35–0.67) overall. A trend of decreasing risk was observed also for the MDP and MAI the ORs for the highest vs the lowest quintile being 0.44 (95% CI 0.27–0.73) for MDP and 0.68 (95% CI 0.42–1.11) for the MAI. The results were consistent across strata of age, sex, education, body mass index, alcohol drinking, tobacco smoking, and diabetes.
Conclusion:
Our study provides evidence that a priori-defined scores measuring adherence to the Mediterranean diet are favourably associated with pancreatic cancer risk.
Similar content being viewed by others
Main
The Mediterranean diet typical of southern European countries has different variants but it is generally characterised by some common features, that is, abundant consumption of plant foods, fresh and varied fruit, high consumption of cereals, frequent consumption of fish, olive oil as the main seasoning fat, moderate consumption of wine mainly during meals, and relatively low intake of meat and dairy products (Trichopoulou and Lagiou, 1997). Several epidemiological studies have indicated that adherence to the Mediterranean dietary pattern has a beneficial role on cardiovascular diseases (Panagiotakos et al, 2002; Sofi et al, 2010; Dilis et al, 2012; Misirli et al, 2012) and overall mortality (Trichopoulou et al, 1995, 2003; Knoops et al, 2004; Trichopoulou et al, 2005; Mitrou et al, 2007; Sofi et al, 2010). In particular, for coronary heart diseases, no particular food has been implicated as causal, but the evidence for a favourable role of the Mediterranean dietary pattern is convincing (Mente et al, 2009). More recently, other studies suggested that the Mediterranean diet has a favourable impact on common cancers as well (Trichopoulou et al, 2000; Bosetti et al, 2003; Pelucchi et al, 2009; Buckland et al, 2010; Verberne et al, 2010; Couto et al, 2011; Bamia et al, 2013; Buckland et al, 2013; Giacosa et al, 2013).
Adherence to a Mediterranean diet pattern may also have a beneficial role on pancreatic cancer, although only a few studies have evaluated such an association. The US prospective National Institutes of Health-AARP Diet and Health study, including a total of 450 416 participants and 1057 pancreatic cancer cases, reported a relative risk (RR) of 0.92 (95% confidence interval (CI) 0.81–1.05) for high (5–8 points) vs low (0–4 points) no-alcohol Mediterranean dietary score. The risk reduction comparing the most extreme categories of the dietary score (7–8 points vs 0–1) was 27%, although it was not significant (P=0.06) (Jiao et al, 2009). In a cohort study from Sweden on 77 151 participants and including 92 pancreatic cancer cases, the Mediterranean diet score (MDS) was significantly inversely related to pancreatic cancer risk (RR=0.82, 95% CI 0.72–0.94) (Tognon et al, 2012). The adherence to various aspects of the Mediterranean diet, however, is likely to be much lower in those countries than in Italy.
We have therefore evaluated the hypothesis that the Mediterranean diet has a beneficial role on the risk of pancreatic cancer using data from two Italian case–control studies (Turati et al, 2011). To measure the adherence to the Mediterranean diet, we used three different a priori-defined scores proposed in the literature to combine various foods/food groups, and adopted in various other epidemiological studies (Bach et al, 2006). This is an alternative approach to that used in one of the Italian studies (Bosetti et al, 2013), where nutrient-based dietary patterns were identified using an exploratory a posteriori approach, built on the specific dietary data under consideration.
Materials and methods
We analysed data from two hospital-based case–control studies of pancreatic cancer conducted in Italy. Briefly, the first one was conducted between 1983 and 1992 in the province of Milan on 362 incident cases of pancreatic cancer (229 men, 133 women, median age 60 years, range 18–86) and 1552 controls (1114 men, 411 women, median age 56 years, range 18–84) (La Vecchia et al, 1990); the second study was conducted between 1992 and 2008 in the provinces of Milan and Pordenone (northern Italy) on 326 incident cases (174 men, 152 women, median age 62 years, range 34–80) and 652 controls (348 men, 304 women, median age 62 years, range 34–80), frequency-matched to cases by age, sex, and study centre (ratio 2 : 1) (Polesel et al, 2010). In both studies, controls were subjects admitted to the same network of hospitals as cases for a wide spectrum of acute, non-neoplastic conditions. Overall, 30% were admitted for traumas, 21% for non-traumatic orthopaedic disorders, 33% for acute surgical conditions, and 16% for miscellaneous other illnesses, including eye, ear, nose, throat, skin, or dental disorders. Less than 5% of cases and controls approached for interview refused to participate.
Cases and controls were personally interviewed by centrally trained interviewers using similar structured questionnaires, including information on socio-demographic characteristics, anthropometric measures (including self-reported weight and height), tobacco smoking, alcohol drinking, other lifestyle habits, and personal medical history of selected diseases. In the first study, subjects’ usual diet before cancer diagnosis or hospital admission (for controls) was investigated using a simplified dietary section, including weekly frequency of consumption of 14 selected indicator foods. Subjective scores (low, medium, and high) were used to obtain information on (whole grain) cereals and seasoning fats intake (butter, margarine, and olive oil). In the second study, subjects’ usual diet during the 2 years before cancer diagnosis or hospital admission (for controls) was assessed through a validated and reproducible food frequency questionnaire (Franceschi et al, 1993; Decarli et al, 1996), including 78 foods and beverages, as well as a range of recipes, that is, the most common ones in the Italian diet, grouped into seven sections: (i) bread and cereal dishes (first courses); (ii) meat and other main dishes (second courses); (iii) vegetables (side dishes); (iv) fruit; (v) sweets, desserts, and soft drinks; (vi) milk and hot beverages; and (vii) alcoholic beverages. Subjects were asked to indicate the average weekly frequency of consumption of each dietary item; occasional intake (lower than once a week, but at least once a month) was coded as 0.5 per week. An Italian food composition database, integrated with other sources, was used to estimate nutrient and total energy intake in this study (Salvini et al, 1998; Gnagnarella et al, 2004).
In both studies, we defined an a priori score (the MDS) on the basis of nine (eight for the first study) characteristics of the traditional Mediterranean diet, as suggested by Trichopoulou et al (1995) (Supplementary Table): high consumption of cereals, fruit, vegetables, legumes (for the second study only), and fish; high monounsaturated/saturated fat ratio; low consumption of milk and dairy products, and meat and meat products; and moderate alcohol intake. The cut points for the items considered were set to study- and sex-specific median values among controls. For each subject, one point was attributed for the presence of each characteristic; for alcohol, one point was attributed to moderate drinkers (consumption over 0 and below the median), and none to non or heavy drinkers (consumption above the median). We then summed up the points for all the nine (or eight in the first study) items to calculate the MDS, which thus ranged between zero (no adherence) and nine (or eight) (maximum adherence).
Two further scores of adherence to the Mediterranean diet were applied in the second study only, the Mediterranean Dietary Pattern Adherence Index (MDP) and the Mediterranean Adequacy Index (MAI). The MDP was calculated by summing up the standardised residuals of the regression of cereals, fruit, vegetables, legumes, moderate alcohol, monounsaturated to saturated fat ratio on total calories, and subtracting those of milk and meat. The MDP was then expressed as a percentage of adherence using the range of the values in the sample, and assumed values between 0% (low adherence) and 100% (maximum adherence) (Sanchez-Villegas et al, 2002). Mediterranean Adequacy Index was calculated by dividing the sum of the intake of seleted typical Mediterranean foods (i.e., bread, cereals, fruit, vegetables, legumes, potatoes, fish, red wine, and vegetable oils) as a percentage of total energy by the sum of the intake of non-typical Mediterranean foods (i.e., milk, cheese, meat, eggs, animal fats and margarines, sweet beverages, cakes, pies and cookies, and sugar) again as the percentage of total energy (Alberti-Fidanza and Fidanza, 2004). In our population, this score ranged between 0.33 and 14.18. The MDP score had a possitive correlation with the MDS (Pearson correlation coefficient=0.59), while the correlation coefficient was 0.29 between the MAI and the MDS.
We estimated odds ratios (ORs) and the corresponding 95% CI of pancreatic cancer for categories of the three scores by unconditional multiple logistic regression models (Breslow and Day, 1980), including terms for age (5-year groups), sex, centre, calendar year at diagnosis, years of education (<7, 7–11, and ⩾12), body mass index (BMI, <25, 25–29.9, and ⩾30 kg m−2), tobacco consumption (never, ex-smoker, and current smoker of <15 and ⩾15 cigarettes per day), history of diabetes (no and yes), and total energy intake (quintiles, available for the second study only). Overall risk estimates for the two studies combined were further adjusted by study. We also computed continuous ORs, for an increment of one unit for MDS and MAI, and of 10 units for the MDP.
To investigate whether the associations with the three dietary scores was homogeneous across strata of selected covariates, we conducted analyses stratified by sex, age, education, BMI, tobacco smoking, alcohol consumption, and history of diabetes. Heterogeneity across strata was tested by likelihood ratio tests and resulting χ2 statistics.
Results
Table 1 shows the distribution of pancreatic cancer cases and corresponding controls by selected covariates. As compared with controls, cases were more frequently of female sex, were somewhat older, had a lower BMI, were more frequently heavy smoker, and reported more frequently a history of diabetes. No difference was observed with reference to education and alcohol drinking.
The distribution of pancreatic cancer cases and controls, and the corresponding ORs according to the MDS (separately for the two studies and overall) are given in Table 2. A significant reduced risk of pancreatic cancer was found for increasing levels of the MDS: the ORs for subjects with six or more Mediterranean characteristics, compared with those with less than three characteristics, were 0.57 (95% CI 0.34–0.95) in the first study, 0.51 (95% CI 0.29–0.92) in the second study, and 0.48 (95% CI 0.35–0.67) overall. The continuous ORs for a unit increment of the MDS were 0.88 (95% CI 0.81–0.95) in the first study, 0.89 (95% CI 0.81–0.99) in the second study, and 0.85 (95% CI 0.80–0.91) overall. In sensitivity analyses, the overall continuous OR was 0.84 (95% CI 0.79–0.90) after excluding milk from the MDS, 0.83 (95% CI 0.78–0.88) after excluding cereals, 0.86 (95% CI 0.81–0.92) after excluding fruit, 0.84 (95% CI 0.79–0.90) after excluding vegetables, 0.87 (95% CI 0.82–0.93) after excluding meat, 0.85 (95% CI 0.79–0.90) after excluding fish, 0.85 (95% CI 0.80–0.91) after excluding alcohol, and 0.83 (95% CI 0.78–0.89) after excluding monounsaturated to saturated fat ratio.
The association for a continuous increment of the MDS was consistent across strata of age, BMI, alcohol drinking, and tobacco smoking (Table 3). The inverse relation with pancreatic cancer was stronger in subjects with a lower level of education as compared with those with a higher level (OR=0.79 and 0.91, respectively, P for heterogeneity between strata=0.0095) and in those with no history of diabetes as compared with those with a history of diabetes (OR=0.84 and 0.99, respectively, P for heterogeneity between strata=0.01).
Table 4 shows the distribution of pancreatic cancer cases and controls and corresponding ORs according to the MDP and MAI. A trend of decreasing risk was observed for both scores, with ORs comparing the highest vs the lowest quintile of 0.44 (95% CI 0.27–0.72) for the MDP and of 0.68 (95% CI 0.42–1.11) for MAI. The ORs were 0.79 (95% CI 0.69–0.90) for a 10-unit increment of the MDP and 0.82 (95% CI 0.69–0.98) for a 1-unit increment of the MAI. The results for the MDP and MAI were consistent across strata of age, sex, education, BMI, alcohol drinking, tobacco smoking, and diabetes (data not shown).
Discussion
Our study provides evidence that a priori-defined scores that include several aspects of the Mediterranean diet are favourably associated with pancreatic cancer risk. Such beneficial role is not meaningfully modified by allowance for known risk factors for this neoplasm, such as BMI, tobacco, alcohol, and diabetes. Moreover, as reported in two other studies that analysed pancreatic cancer risk in relation to Mediterranean diet scores (Jiao et al, 2009; Tognon et al, 2012), the inverse association was consistent in the two sexes.
Among specific components of the Mediterranean diet, vegetables and fruits have been reported to reduce the risk of pancreatic cancer in a few studies, possibly on account of their high content in vitamin C, folate, and phenolic compounds (Larsson et al, 2006; World Cancer Research Fund and American Institute for Cancer Research, 2007; Nothlings et al, 2007b; Hart et al, 2008; Bae et al, 2009; Rossi et al, 2012). However, the evidence is not consistent and a recent report of the World Cancer Research Association has judged the evidence for fruit and vegetables on pancreatic cancer ‘limited–not conclusive’ (Koushik et al, 2012; World Cancer Research Fund and American Institute for Cancer Research, 2012).
Olive oil, the most commonly used seasoning fat and the main source of monounsaturated fatty acid in Mediterranean countries, has also been reported to be a favourable indicator of various common cancers (Pelucchi et al, 2011), although data on pancreatic cancer are scanty (La Vecchia and Negri, 1997). A possible beneficial role of olive oil on cancer has been explained in terms of its strong antioxidant properties, owing to the specific fatty acid composition, as well as to the presence of various nutrients, such as vitamin E and polyphenols (Owen et al, 2000; Pelucchi et al, 2011). However, olive oil may simply be an indicator of a healthier diet, richer in vegetables and other plant foods.
Refined cereals (such as bread, pasta, or rice), frequently consumed in Italy, have been hypothesised to increase pancreatic cancer risk, through mechanisms involving insulin, insulin resistance, and insulin-like growth factors, and this is reflected in the estimates above unity for cereals in the present study (Polesel et al, 2010; Rossi et al, 2010). However, most epidemiological data do not indicate that a high intake of carbohydrates has a detrimental role on pancreatic cancer (World Cancer Research Fund and American Institute for Cancer Research, 2007; Nothlings et al, 2007a; Hart et al, 2008; Aune et al, 2012).
A direct association between pancreatic cancer and meat, particularly red meat, has been reported in several epidemiological studies (Stolzenberg-Solomon et al, 2007; World Cancer Research Fund and American Institute for Cancer Research, 2007; Zheng and Lee, 2009; Polesel et al, 2010; Anderson et al, 2012; Larsson and Wolk, 2012). Thus, the limited intake of (red) meat is another characteristic of the Mediterranean diet, which favourably influences pancreatic cancer risk. The association with red meat has been attributed to heterocyclic amines, polycyclic aromatic hydrocarbons, and nitrosamines produced in meat cooking, though the interpretation remains open to discussion (Tavani et al, 2000; Risch, 2003; Anderson et al, 2005).
The limited intake of animal foods and fats from animal sources, which characterises the Mediterranean diet, may also contribute to its favourable role in pancreatic cancer, although the evidence of the role of animal foods other than meat, including milk and dairy products, eggs, and fish, and of (saturated) fats on this nepolasm, is limited and inconsistent (World Cancer Research Fund and American Institute for Cancer Research, 2007; Hart et al, 2008).
Finally, heavy – but not low/moderate – alcohol intake has been associated with an increased pancreatic cancer risk (Tramacere et al, 2010; Genkinger et al, 2011; Lucenteforte et al, 2012). Thus, the regular but moderate consumption of wine mainly during meals, characteristic of the Mediterranean diet, is not an unfavourable indicator of pancreatic cancer.
More than on single dietary aspects, however, the interest of this study has to be related to the strong inverse relationship between pancreatic cancer and the combination of various food items into a priori-defined scores that take into consideration the synergistic effects or interactions of foods and nutrients characteristic of the Mediterranean diet. Thus, the combination of the favourable fatty acid profile, high fibre content, antioxidants and phytochemicals typical of the Mediterranean diet, and their synergistic effect appear to have a beneficial role on pancreatic, as on other cancers (Trichopoulou et al, 2000; Bosetti et al, 2003; Pelucchi et al, 2009; Buckland et al, 2010; Verberne et al, 2010; Couto et al, 2011; Buckland et al, 2013; Giacosa et al, 2013).
With reference to possible sources of bias inherent to case–control studies, in order to reduce any potential information bias, the questionnaires were administered to both cases and controls by the same interviewers, under similar condition. Dietary habits of hospital-controls may be different from those of the general population, but we paid attention to exclude from the control group all diagnoses associated with long-term dietary modifications. Potential recall bias should be limited, given the limited appreciation by the Italian population of a link between diet and pancreatic cancer risk at the time of interview. To reduce any possible dietary modification bias due to the recent cancer diagnosis, we asked for habitual dietary habits before cancer diagnosis, although diet could have changed before owing to subclinical disease. Among the limitations of the study is the short dietary questionnaire of the first study. However, the consistency of the results in the two studies, conducted in different calendar periods and using different dietary questionnaires gives further support to the finding of a beneficial role of the Mediterranean diet on pancreatic cancer. Among the strengths of the study are the relatively large sample size, the almost complete participation of cases and controls, the comparable catchment areas of study subjects, and the accurate control for major recognised risk factors for pancreatic cancer. As other healthy behaviours may be associated with a better diet, unaccounted confounding could partly explain the observed inverse association. The major strength of the study is the application of a priori and independently developed Mediterranean scores to a population with a considerable variability with respect to these scores, while other studies on the issue were conducted in non-Mediterranean populations. The comparability of the results obtained from a simple intuitive score (MDS) adopted in various previous epidemiological studies and from two other more complex a priori scores (MDP and MAI) proposed to evaluate the adherence to the Mediterranean diet also supports our findings of a beneficial role of the Mediterranean diet on pancreatic cancer.
Change history
03 September 2013
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alberti-Fidanza A, Fidanza F (2004) Mediterranean Adequacy Index of Italian diets. Public Health Nutr 7: 937–941.
Anderson KE, Kadlubar FF, Kulldorff M, Harnack L, Gross M, Lang NP, Barber C, Rothman N, Sinha R (2005) Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14: 2261–2265.
Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR (2012) Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog 51: 128–137.
Aune D, Chan DS, Vieira AR, Navarro Rosenblatt DA, Vieira R, Greenwood DC, Cade JE, Burley VJ, Norat T (2012) Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 23: 2536–2546.
Bach A, Serra-Majem L, Carrasco JL, Roman B, Ngo J, Bertomeu I, Obrador B (2006) The use of indexes evaluating the adherence to the Mediterranean diet in epidemiological studies: a review. Public Health Nutr 9: 132–146.
Bae JM, Lee EJ, Guyatt G (2009) Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review. Pancreas 38: 168–174.
Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, Overvad K, Olsen A, Tjonneland A, Cottet V, Boutron-Ruault MC, Morois S, Grote V, Teucher B, Boeing H, Buijsse B, Trichopoulos D, Adarakis G, Tumino R, Naccarati A, Panico S, Palli D, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Engeset D, Skeie G, Lund E, Sanchez MJ, Barricarte A, Huerta JM, Quiros JR, Dorronsoro M, Ljuslinder I, Palmqvist R, Drake I, Key TJ, Khaw KT, Wareham N, Romieu I, Fedirko V, Jenab M, Romaguera D, Norat T, Trichopoulou A (2013) Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol 28: 317–328.
Bosetti C, Bravi F, Turati F, Edefonti V, Polesel J, Decarli A, Negri E, Talamini R, Franceschi S, La Vecchia C, Zeegers MP (2013) Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol 23: 124–128.
Bosetti C, Gallus S, Trichopoulou A, Talamini R, Franceschi S, Negri E, La Vecchia C (2003) Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 12: 1091–1094.
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. Vol. I. The Analysis of Case-Control Studies. IARC Sci Publ No. 32. IARC: Lyon, France.
Buckland G, Agudo A, Lujan L, Jakszyn P, Bueno-de-Mesquita HB, Palli D, Boeing H, Carneiro F, Krogh V, Sacerdote C, Tumino R, Panico S, Nesi G, Manjer J, Regner S, Johansson I, Stenling R, Sanchez MJ, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Allen NE, Key TJ, Bingham S, Kaaks R, Overvad K, Jensen M, Olsen A, Tjonneland A, Peeters PH, Numans ME, Ocke MC, Clavel-Chapelon F, Morois S, Boutron-Ruault MC, Trichopoulou A, Lagiou P, Trichopoulos D, Lund E, Couto E, Boffeta P, Jenab M, Riboli E, Romaguera D, Mouw T, Gonzalez CA (2010) Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 91: 381–390.
Buckland G, Travier N, Cottet V, Gonzalez C, Lujan-Barroso L, Agudo A, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters P, May A, Bueno-de-Mesquita B, van Duijnhoven FJ, Key T, Allen N, Khaw K, Wareham N, Romieu I, McCormack V, Boutron-Ruault M, Clavel-Chapelon F, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Amiano P, Barricarte A, Rodriguez L, Sanchez M, Chirlaque M, Kaaks R, Teucher B, Boeing H, Bergmann M, Overvad K, Dahm C, Tjonneland A, Olsen A, Manjer J, Wirfalt E, Hallmans G, Johansson I, Lund E, Hjartaker A, Skeie G, Vergnaud A, Norat T, Romaguera D, Riboli E (2013) Adherence to the Mediterranean diet and risk of breast cancer in the EPIC cohort study. Int J Cancer 132: 2918–2927.
Couto E, Boffetta P, Lagiou P, Ferrari P, Buckland G, Overvad K, Dahm CC, Tjonneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Cottet V, Trichopoulos D, Naska A, Benetou V, Kaaks R, Rohrmann S, Boeing H, von Ruesten A, Panico S, Pala V, Vineis P, Palli D, Tumino R, May A, Peeters PH, Bueno-de-Mesquita HB, Buchner FL, Lund E, Skeie G, Engeset D, Gonzalez CA, Navarro C, Rodriguez L, Sanchez MJ, Amiano P, Barricarte A, Hallmans G, Johansson I, Manjer J, Wirfart E, Allen NE, Crowe F, Khaw KT, Wareham N, Moskal A, Slimani N, Jenab M, Romaguera D, Mouw T, Norat T, Riboli E, Trichopoulou A (2011) Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer 104: 1493–1499.
Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, La Vecchia C, Negri E, Salvini S, Falcini F, Giacosa A (1996) Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol 6: 110–118.
Dilis V, Katsoulis M, Lagiou P, Trichopoulos D, Naska A, Trichopoulou A (2012) Mediterranean diet and CHD: the Greek European Prospective Investigation into Cancer and Nutrition cohort. Br J Nutr 108: 699–709.
Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, Filiberti R, Giacosa A, Talamini R, Nanni O, Panarello G et al (1993) Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A: 2298–2305.
Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson SC, Leitzmann M, Mannisto S, Marshall JR, Miller AB, Patel AV, Rohan TE, Stolzenberg-Solomon RZ, Verhage BA, Virtamo J, Willcox BJ, Wolk A, Ziegler RG, Smith-Warner SA (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129: 1708–1717.
Giacosa A, Barale R, Bavaresco L, Gatenby P, Gerbi V, Janssens J, Johnston B, Kas K, La Vecchia C, Mainguet P, Morazzoni P, Negri E, Pelucchi C, Pezzotti M, Rondanelli M (2013) Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev 22: 90–95.
Gnagnarella P, Parpinel M, Salvini S, Franceschi S, Palli D, Boyle P (2004) The update of the Italian food composition database. J Food Comp Analysis 17: 509–522.
Hart AR, Kennedy H, Harvey I (2008) Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 6: 275–282.
Jiao L, Mitrou PN, Reedy J, Graubard BI, Hollenbeck AR, Schatzkin A, Stolzenberg-Solomon R (2009) A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med 169: 764–770.
Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA (2004) Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292: 1433–1439.
Koushik A, Spiegelman D, Albanes D, Anderson KE, Bernstein L, van den Brandt PA, Bergkvist L, English DR, Freudenheim JL, Fuchs CS, Genkinger JM, Giles GG, Goldbohm RA, Horn-Ross PL, Mannisto S, McCullough ML, Millen AE, Miller AB, Robien K, Rohan TE, Schatzkin A, Shikany JM, Stolzenberg-Solomon RZ, Willett WC, Wolk A, Ziegler RG, Smith-Warner SA (2012) Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Am J Epidemiol 176: 373–386.
La Vecchia C, Negri E (1997) Fats in seasoning and the relationship to pancreatic cancer. Eur J Cancer Prev 6: 370–373.
La Vecchia C, Negri E, D'Avanzo B, Ferraroni M, Gramenzi A, Savoldelli R, Boyle P, Franceschi S (1990) Medical history, diet and pancreatic cancer. Oncology 47: 463–466.
Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131: 1271–1283.
Larsson SC, Wolk A (2012) Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer 106: 603–607.
Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Gao YT, Negri E, Hassan M, Cotterchio M, Su J, Maisonneuve P, Boffetta P, Duell EJ (2012) Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 23: 374–382.
Mente A, de Koning L, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169: 659–669.
Misirli G, Benetou V, Lagiou P, Bamia C, Trichopoulos D, Trichopoulou A (2012) Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population. Am J Epidemiol 176: 1185–1192.
Mitrou PN, Kipnis V, Thiebaut AC, Reedy J, Subar AF, Wirfalt E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A (2007) Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 167: 2461–2468.
Nothlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2007a) Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Am J Clin Nutr 86: 1495–1501.
Nothlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2007b) Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol 166: 924–931.
Owen RW, Giacosa A, Hull WE, Haubner R, Wurtele G, Spiegelhalder B, Bartsch H (2000) Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol 1: 107–112.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas P (2002) Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 Epidemiological Study. Prev Med 35: 548–556.
Pelucchi C, Bosetti C, Negri E, Lipworth L, La Vecchia C (2011) Olive oil and cancer risk: an update of epidemiological findings through 2010. Curr Pharm Des 17: 805–812.
Pelucchi C, Bosetti C, Rossi M, Negri E, La Vecchia C (2009) Selected aspects of Mediterranean diet and cancer risk. Nutr Cancer 61: 756–766.
Polesel J, Talamini R, Negri E, Bosetti C, Boz G, Lucenteforte E, Franceschi S, Serraino D, La Vecchia C (2010) Dietary habits and risk of pancreatic cancer: an Italian case-control study. Cancer Causes Control 21: 493–500.
Risch HA (2003) Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 95: 948–960.
Rossi M, Lipworth L, Polesel J, Negri E, Bosetti C, Talamini R, McLaughlin JK, La Vecchia C (2010) Dietary glycemic index and glycemic load and risk of pancreatic cancer: a case-control study. Ann Epidemiol 20: 460–465.
Rossi M, Lugo A, Lagiou P, Zucchetto A, Polesel J, Serraino D, Negri E, Trichopoulos D, La Vecchia C (2012) Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol 23: 1488–1493.
Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A (1998) Banca di composizione degli alimenti per studi epidemiologici in Italia. Istituto Europeo di Oncologia: Milan, Italy.
Sanchez-Villegas A, Martinez JA, De Irala J, Martinez-Gonzalez MA (2002) Determinants of the adherence to an ‘a priori’ defined Mediterranean dietary pattern. Eur J Nutr 41: 249–257.
Sofi F, Abbate R, Gensini GF, Casini A (2010) Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 92: 1189–1196.
Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Sinha R (2007) Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 16: 2664–2675.
Tavani A, La Vecchia C, Gallus S, Lagiou P, Trichopoulos D, Levi F, Negri E (2000) Red meat intake and cancer risk: a study in Italy. Int J Cancer 86: 425–428.
Tognon G, Nilsson LM, Lissner L, Johansson I, Hallmans G, Lindahl B, Winkvist A (2012) The Mediterranean diet score and mortality are inversely associated in adults living in the subarctic region. J Nutr 142: 1547–1553.
Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, Corrao G, Bravi F, Boffetta P, La Vecchia C (2010) Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer 126: 1474–1486.
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348: 2599–2608.
Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, Vassilakou T, Lipworth L, Trichopoulos D (1995) Diet and overall survival in elderly people. BMJ 311: 1457–1460.
Trichopoulou A, Lagiou P (1997) Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev 55: 383–389.
Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D (2000) Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 9: 869–873.
Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, van der Schouw YT, Boeing H, Hoffmann K, Boffetta P, Nagel G, Masala G, Krogh V, Panico S, Tumino R, Vineis P, Bamia C, Naska A, Benetou V, Ferrari P, Slimani N, Pera G, Martinez-Garcia C, Navarro C, Rodriguez-Barranco M, Dorronsoro M, Spencer EA, Key TJ, Bingham S, Khaw KT, Kesse E, Clavel-Chapelon F, Boutron-Ruault MC, Berglund G, Wirfalt E, Hallmans G, Johansson I, Tjonneland A, Olsen A, Overvad K, Hundborg HH, Riboli E, Trichopoulos D (2005) Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 330: 991.
Turati F, Galeone C, Talamini R, Franceschi S, Manzari M, Gallino G, Polesel J, La Vecchia C, Tavani A (2011) Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooled-analysis of two Italian case-control studies. Eur J Cancer Prev 20: 287–292.
Verberne L, Bach-Faig A, Buckland G, Serra-Majem L (2010) Association between the Mediterranean diet and cancer risk: a review of observational studies. Nutr Cancer 62: 860–870.
World Cancer Research Fund and American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. AICR: Washington DC.
World Cancer Research Fund and American Institute for Cancer Research (2012) Food, Nutrition, Physical Activity and Pancreatic Cancer. AICR: Washington DC.
Zheng W, Lee SA (2009) Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61: 437–446.
Acknowledgements
This work was conducted with the contribution of the Italian Association for Cancer Research (Grant N. 10068). FT was supported by a fellowship from the Italian Foundation for Cancer Research (FIRC). The authors thank Mrs Ivana Garimoldi for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
Supplementary Information accompanies this paper on British Journal of Cancer website
Supplementary information
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bosetti, C., Turati, F., Pont, A. et al. The role of Mediterranean diet on the risk of pancreatic cancer. Br J Cancer 109, 1360–1366 (2013). https://doi.org/10.1038/bjc.2013.345
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2013.345
Keywords
This article is cited by
-
Diabetes risk reduction diet and the risk of pancreatic cancer
European Journal of Nutrition (2022)
-
An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies
European Journal of Nutrition (2020)
-
Primary and Secondary Prevention of Pancreatic Cancer
Current Epidemiology Reports (2019)
-
The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies
Rheumatology International (2018)
-
Adherence to the Mediterranean diet and nasopharyngeal cancer risk in Italy
Cancer Causes & Control (2017)